RDGT Ridgetech Inc.

$0.85 +2.41%

Data as of Oct 30, 2026 close

Consumer Defensive · Retail-Drug Stores And Proprietary Stores

Ridgetech Inc. (RDGT) is a consumer defensive company in the Retail-Drug Stores And Proprietary Stores industry, with a market capitalization of $113 million. Shares last traded at $0.85, 99.9% below their 52-week high. Over the past year the stock is down 99.6%. Net profit margin is -0.9%, below the peer median of -0.2%. Revenue grew 10.2% year over year.

Market Cap

$113M

Shares Out

133.1M

EPS (TTM)

-$17.21

P/E (TTM)*

—

P/S Ratio

0.86

P/B Ratio

2.78

Dividend / Share

—

Dividend Yield

—

52-Week High

$748.50

52-Week Low

$0.67

Volume (venue)

102

Avg Vol (3m, venue)

21,158.794

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

+4.39%

-7.54%

-38.80%

-56.37%

YTD

-99.83%

-99.56%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. RDGT split history →

Technicals

RSI (14)

47.12

SMA (50)

$0.88

SMA (200)

$123.06

Price vs SMA50

-3.22%

Price vs SMA200

-99.31%

ATR (14)

$0.07

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$132M

Net Income

-$1M

Gross Margin

3.6%

Operating Margin

-1.4%

Net Margin

-0.9%

Return on Equity

-3.1%

Return on Assets

-1.8%

Current Ratio

2.31

Debt / Equity

0.05

Revenue Growth (YoY)

+10.2%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-03-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Retail-Drug Stores And Proprietary Stores peers

RDGT vs 5 industry peers (Retail-Drug Stores And Proprietary Stores), by market cap. Data as of Oct 30, 2026 close

P/S vs peers

0.86 / 0.57 med

+50% premium

Net margin vs peers

-0.9% / -0.2% med

below median

1–5 of 5


CVS	CVS Health	$117.3B	23.98	0.28	1.2%	+3.59%
GRDN	Guardian Pharmacy Services, Inc.	$2.6B	39.30	1.77	4.5%	+2.29%
RDGT	Ridgetech Inc.	$113M	—	0.86	-0.9%	+2.41%
PETS	PETMED EXPRESS INC	$26M	—	0.15	-17.3%	-0.42%
YI	111, Inc.	—	—	—	-0.2%	+0.66%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.